BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28416108)

  • 1. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):454-455. PubMed ID: 28416108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution.
    Khor LY; Dhakal HP; Jia X; Reynolds JP; McKenney JK; Rini BI; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Sep; 40(9):1224-31. PubMed ID: 27428737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
    Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
    Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis.
    Avulova S; Cheville JC; Lohse CM; Gupta S; Potretzke TA; Tsivian M; Thompson RH; Boorjian SA; Leibovich BC; Potretzke AM
    Eur Urol; 2021 Feb; 79(2):225-231. PubMed ID: 33172723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.
    Przybycin CG; McKenney JK; Reynolds JP; Campbell S; Zhou M; Karafa MT; Magi-Galluzzi C
    Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study.
    Choi J; Bang S; Suh J; Choi CI; Song W; Yuk HD; Lee CH; Kang M; Choo SH; Kim JK; Lee HH; Jo JK; Hwang EC; Jeong CW; Ko YH; Park JY; Song C; Seo SI; Chung J; Kwak C; Hong SH
    Sci Rep; 2024 Feb; 14(1):4740. PubMed ID: 38413653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Percentage Necrosis in Clear Cell Renal Cell Carcinoma.
    Syed M; Loya A; Hameed M; Akhtar N; Mushtaq S; Hassan U
    Am J Clin Pathol; 2022 Mar; 157(3):374-380. PubMed ID: 34643216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
    Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
    BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
    Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
    Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
    Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma.
    Galtung KF; Lauritzen PM; Baco E; Berg RE; Naas AM; Rud E
    Anticancer Res; 2022 Jun; 42(6):2967-2975. PubMed ID: 35641263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
    Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ
    Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.